targapremir-210 | Interleukin Related interleukin-related.com

Product Name :
targapremir-210

Search keywords :
Targapremir-210

drugId :
null

Target Vo:
Mitochondrial permeability transition pore

Target Vo Short Name :
mPTP

Moa_Name:
Mitochondrial permeability transition pore inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
The Scripps Research Institute Inc

Active Company_Name :
The Scripps Research Institute Inc

Active Indication_Name:
Neoplasms

In Active Indication_Name:

Termination Status :

China Termination Status :

Highest Status:
Preclinical

China Highest Status:

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
Phospho-Smad2 (Ser250) Antibody
FKBP52 Antibody
BRAF Antibody: BRAF Antibody is a non-conjugated and Mouse origined monoclonal antibody about 84 kDa, targeting to BRAF (4E1). It can be used for WB assays with tag free, in the background of Human, Mouse.

Author: Interleukin Related

Related Posts